| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |